RTW Investments, LP 13D/13G Filings for Kalaris Therapeutics Inc (KLRS)

RTW Investments, LP 13D and 13G filings for Kalaris Therapeutics Inc:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-02-17
08:37 am
Purchase
2025-12-3113GKALARIS THERAPEUTICS INC
KLRS
RTW Investments, LP1,300,000
5.700%
1,300,000increase
(New Position)
Filing